Vatalanib, a tyrosine kinase inhibitor, decreases hepatic fibrosis and sinusoidal capillarization in CCl4-induced fibrotic mice.
about
Vatalanib, a tyrosine kinase inhibitor, decreases hepatic fibrosis and sinusoidal capillarization in CCl4-induced fibrotic mice.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Vatalanib, a tyrosine kinase i ...... in CCl4-induced fibrotic mice.
@en
Vatalanib, a tyrosine kinase i ...... in CCl4-induced fibrotic mice.
@nl
type
label
Vatalanib, a tyrosine kinase i ...... in CCl4-induced fibrotic mice.
@en
Vatalanib, a tyrosine kinase i ...... in CCl4-induced fibrotic mice.
@nl
prefLabel
Vatalanib, a tyrosine kinase i ...... in CCl4-induced fibrotic mice.
@en
Vatalanib, a tyrosine kinase i ...... in CCl4-induced fibrotic mice.
@nl
P2093
P2860
P356
P1476
Vatalanib, a tyrosine kinase i ...... in CCl4-induced fibrotic mice.
@en
P2093
Feng-Hua Pei
Liao-Liao Zhao
Ling-Jian Kong
P2860
P304
P356
10.3892/MMR.2017.6325
P577
2017-03-15T00:00:00Z